Treatment with anti-alpha2 integrin antibodies

Details for Australian Patent Application No. 2009312532 (hide)

Owner Glenmark Pharmaceuticals S.A.

Inventors Mottl, Harald

Agent Freehills

Pub. Number AU-A-2009312532

PCT Pub. Number WO2010/052556

Priority 61/111,932 06.11.08 US

Filing date 5 November 2009

Wipo publication date 14 May 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

19 May 2011 PCT application entered the National Phase

  PCT publication WO2010/052556 Priority application(s): WO2010/052556

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009312535-Cycloundecadepsipeptide compounds and use of said compounds as a medicament

2009312516-Communication interface apparatus for an electrical distribution panel, and system and electrical distribution panel including the same